Sangamo BioSciences’ (SGMO) CEO Edward Lanphier on Deutsche Bank 39th Annual Health Care Conference (Transcript)
[at Seeking Alpha] – What we propose to do is human genetic engineering physically change and permanently change DNA sequences in a way that we can control the biology of that cell that will be modified that gene. So that’s … moreView todays social media effects on SGMOView the latest stocks trending across Twitter. Click to view dashboardSee who Sangamo […]